Clinical Trial Update: Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for the OTSGC-A24 vaccine in advanced gastric cancer, sponsored by National University Hospital, Singapore.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OTSGC-A24 vaccine

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN